{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH/NCBI Data Team", "hasEmail": "mailto:info@ncbi.nlm.nih.gov"}, "description": "The present invention relates to the treatment of dementia and neurodegenerative diseases like Alzheimer's disease with intermediate doses of LHRH antagonists which do not cause a castration. A preferred LHRH antagonist is cetrorelix.", "distribution": [{"@type": "dcat:Distribution", "description": "Access the complete Patent AT-E400287-T1: [Translated] LOW DOSE LHRH ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR ALZHEIMER'S DISEASE on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400287-T1", "mediaType": "text/html", "title": "Official Data Source"}], "identifier": "https://healthdata.gov/api/views/2ddn-smki", "issued": "2025-09-05", "keyword": ["chemistry", "innovation", "patent", "pubchem", "research"], "landingPage": "https://healthdata.gov/d/2ddn-smki", "modified": "2025-09-06", "programCode": ["009:066"], "publisher": {"@type": "org:Organization", "name": "National Center for Biotechnology Information (NCBI)"}, "theme": ["NIH"], "title": "Patent AT-E400287-T1: [Translated] LOW DOSE LHRH ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR ALZHEIMER'S DISEASE"}